• News
  • Health

Accelrys buys Swiss partner

Related Special Reports

Accelrys Inc., a provider of scientific innovation lifecycle management software, bought longtime partner Vialis AG.

Under terms of the deal, San Diego-based Accelrys (Nasdaq: ACCL) bought all of Vialis' outstanding stock for approximately $5 million in cash.

The Liestal, Switzerland-based systems integrator serves the pharmaceutical, biotechnology, chemicals and agro-science industries.

Vialis' experience implementing and supporting paperless laboratory solutions further strengthens Accelrys' position in the laboratory informatics software market and expands the company's capabilities in the downstream analytical development, quality control, and quality assurance and manufacturing areas.

The acquisition includes potential for additional incentive consideration of up to approximately $5 million in cash, contingent upon meeting specified growth objectives over the next three years.

"This acquisition is a natural complement to our two most recent software acquisitions of Velquest and Aegis Corp., furthering our strategy to deliver software solutions that optimize the laboratory-to-commercialization value chain," said Accelrys President and CEO Max Carnecchia.

Accelrys's brainy team includes more than 200 full-time Ph.D. scientists.

The entire Vialis team is joining Accelrys and will be primarily focused on enhancing product and process insight, facilitating collaboration and streamlining product development from research through late-stage quality control and manufacturing.

Accelrys solutions are used by more than 1,300 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries.


R&D software company Accelrys acquires VelQuest

User Response
0 UserComments